TAFINLAR (dabrafenib)

TAFINLAR is a targeted therapy designed to help address cancers driven by specific BRAF gene mutations. By targeting abnormal signaling pathways involved in tumor growth, TAFINLAR® plays an important role in personalized treatment approaches for eligible patients.

Category:

Description

TAFINLAR (dabrafenib)

Advancing Targeted Cancer Treatment

TAFINLAR® is a targeted therapy designed to help address cancers driven by specific BRAF gene mutations. By targeting abnormal signaling pathways involved in tumor growth, TAFINLAR® plays an important role in personalized treatment approaches for eligible patients.

What Is TAFINLAR?

TAFINLAR (dabrafenib) is a prescription medicine that belongs to a class of treatments known as BRAF inhibitors. It is used in certain patients whose cancer contains a BRAF V600 mutation, as determined by an approved diagnostic test.

How TAFINLAR Works

Certain cancers are driven by mutations in the BRAF gene, which can cause uncontrolled cell growth. TAFINLAR® works by inhibiting abnormal BRAF proteins, helping to slow or stop the growth of cancer cells associated with these mutations.

Approved Uses

TAFINLAR may be prescribed for specific types of cancer in eligible patients, subject to local regulatory approvals and prescribing information. Healthcare professionals determine whether treatment is appropriate based on mutation testing, disease type, and individual patient factors.

Personalized Treatment Approach

  • Targeted therapy designed for BRAF mutation-positive cancers
  • Supports precision medicine strategies
  • Used according to approved indications and treatment guidelines
  • Requires confirmation of BRAF mutation status before initiation

For Patients

If you have been diagnosed with a cancer that may be associated with a BRAF mutation, speak with your healthcare provider about whether genetic testing and targeted treatment options may be appropriate for you.

Important Safety Information

TAFINLAR may cause serious side effects. Patients should carefully review the full prescribing information and discuss potential risks and benefits with their healthcare provider before starting treatment.

Do not start, stop, or change treatment without medical advice from a qualified healthcare professional.

Resources

  • Prescribing Information
  • Patient Support Resources
  • Frequently Asked Questions
  • Healthcare Professional Information
  • Contact Us

Disclaimer

This website is intended for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult your healthcare provider regarding any medical condition or treatment decision.

Reviews

There are no reviews yet.

Be the first to review “TAFINLAR (dabrafenib)”

Your email address will not be published. Required fields are marked *